2025-07-11 - Analysis Report
Okay, here's the report on Albemarle Corp (ALB), incorporating all the provided data and analysis requests.

## Albemarle Corp (ALB) Stock Analysis

**Company Overview:** Albemarle Corp is a specialty chemicals company with leading positions in lithium, bromine specialties, and catalysts.

### 1. Performance vs. S&P 500 (VOO)

*   **ALB Cumulative Return:** 23.45%
*   **VOO Cumulative Return:** 96.17%
*   **Absolute Deviation:** -77.73%
*   **Relative Deviation:** 3.1 (Indicates ALB's underperformance relative to VOO is near the lower end of its historical range.)

**Analysis of Alpha/Beta Metrics:**

| Year       | CAGR     | MDD      | Alpha    | Beta  | Cap(B) |
| ---------- | -------- | -------- | -------- | ----- | ------ |
| 2015-2017  | 99.0%    | 8.1%     | 70.0%    | 0.0   | 15.1   |
| 2016-2018  | 13.0%    | 58.0%    | -5.0%    | 0.0   | 9.1    |
| 2017-2019  | -44.0%   | 58.0%    | -74.0%   | -0.0  | 8.6    |
| 2018-2020  | 101.0%   | 62.9%    | 81.0%    | 0.6   | 17.4   |
| 2019-2021  | 268.0%   | 62.9%    | 220.0%   | 0.6   | 27.5   |
| 2020-2022  | 239.0%   | 75.6%    | 237.0%   | 0.8   | 25.5   |
| 2021-2023  | -53.0%   | 77.5%    | -71.0%   | 0.6   | 17.0   |
| 2022-2024  | -200.0%  | 77.5%    | -225.0%  | 0.7   | 10.1   |
| 2023-2025  | -325.0%  | 77.5%    | -373.0%  | 2.9   | 8.7    |

*   **CAGR:** The Compounded Annual Growth Rate demonstrates significant volatility, with periods of high growth followed by substantial declines, particularly in recent years.
*   **MDD:** Maximum Drawdown indicates the largest peak-to-trough decline during the period. High MDD values, especially in recent years (77.5%), suggest substantial risk and price volatility.
*   **Alpha:** Alpha measures the investment's performance on a risk-adjusted basis. Negative Alpha values, especially large negative values in recent periods, indicate that the investment has significantly underperformed its benchmark after accounting for risk.
*   **Beta:** Beta measures the investment's volatility relative to the market. Beta values close to zero for earlier periods suggest that the stock's price movements were largely independent of the broader market. However, recent beta values approaching 2.9, may show that ALB is more volatile than the market
*   **Cap(B):** Market Capitalization. Steady decline from 27.5B to 8.7B

**Analysis:** The data shows a significant underperformance of ALB compared to the S&P 500 (VOO) over the analyzed period. The negative Alpha values and high Maximum Drawdown indicate higher risk and underperformance relative to the benchmark.

### 2. Recent Stock Price Movement

*   **Current Price:** $74.27
*   **Previous Close:** $70.79
*   **Change:** +$3.48 (+4.92%)
*   **5-Day Moving Average:** $69.66
*   **20-Day Moving Average:** $63.70
*   **60-Day Moving Average:** $59.93

**Analysis:** The stock price shows a strong recent upward trend. The price is above all three moving averages (5, 20, and 60 days), which is a bullish signal. The significant positive change from the previous close suggests a strong, sudden upward movement.

### 3. Market Risk Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.3373 (Low Risk)
*   **RSI:** 74.87 (Approaching overbought territory)
*   **PPO:** 1.7861
*   **Hybrid Signal:** "cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.33)"
*   **20-Day Relative Deviation Change:** +3.1 (Indicates recent short-term upward momentum)
*   **Expected Return:** 3884.7% (Long-term, relative to S&P 500)

**Analysis:**

*   The **MRI** indicates low market risk, suggesting that overall market conditions are stable.
*   The **RSI** is nearing the overbought threshold, suggesting the stock might be due for a pullback.
*   The **Hybrid Signal** recommends buying 80% of available cash, but with caution due to the MRI.
*   The positive change in relative deviation further confirms short-term bullish momentum.
*   The extremely high **Expected Return** should be viewed with extreme caution. This likely represents an optimistic, model-driven projection and may not be realistic.

### 4. Recent News & Significant Events

*   **[2025-07-11]:** Major business developments, regulatory changes, or market events impacting Albemarle Corp (ALB).
*   **[2025-07-08]:** Analyst discussions about Albemarle Corp's (ALB) recent performance and outlook in the context of industry trends and global economic factors.
*   **[2025-07-07]:** Albemarle Corp (ALB)'s stock exhibiting notable volatility.
*   **[2025-07-09]:** Market experts highlighting both risks and opportunities for Albemarle Corp (ALB), advising investors to monitor recent news.

**Analysis:** Recent news indicates potential significant events affecting ALB. The volatility mentioned in the news aligns with the stock's historical volatility shown in the Alpha/Beta analysis.

### 5. Recent Earnings Analysis

| Date       | EPS   | Revenue      |
| ---------- | ----- | ------------ |
| 2025-04-30 | 0     | 1.08 B$      |
| 2024-11-06 | -9.45 | 1.35 B$      |
| 2024-07-31 | -1.96 | 1.43 B$      |
| 2024-05-01 | -0.08 | 1.36 B$      |
| 2025-04-30 | -0.08 | 1.36 B$      |

**Analysis:** The provided earnings data reveals fluctuating EPS figures, including periods of significant losses. Revenue has generally decreased over the analyzed quarters.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
| ------------ | ---------- | ------------- |
| 2025-03-31   | $1.08B     | 14.51%        |
| 2024-12-31   | $1.23B     | 11.22%        |
| 2024-09-30   | $1.35B     | -7.68%        |
| 2024-06-30   | $1.43B     | -0.74%        |
| 2024-03-31   | $1.36B     | 2.86%         |

**Capital and Profitability:**

| Quarter      | Equity     | ROE       |
| ------------ | ---------- | --------- |
| 2025-03-31   | $10.03B    | 0.41%     |
| 2024-12-31   | $9.96B    | 0.76%     |
| 2024-09-30   | $10.24B    | -10.44%   |
| 2024-06-30   | $11.22B    | -1.68%    |
| 2024-03-31   | $11.53B    | 0.02%     |

**Analysis:**

*   **Revenue and Profitability:**  Revenue has generally decreased over the analyzed quarters. Profit margins have fluctuated and have been negative in some quarters, indicating challenges in maintaining profitability.
*   **Capital and Profitability:**  Equity has decreased over the period, which may be a concern. ROE (Return on Equity) has been volatile, with negative values indicating losses relative to shareholders' equity in some quarters.

### 7. Overall Summary and Investment Considerations

**Summary:**

Albemarle Corp (ALB) has underperformed the S&P 500 significantly in recent years, with high volatility as shown by the MDD and Beta. Recent news suggests significant market events impacting the stock. While there is a recent upward price trend, earnings and financial data indicate declining revenue, volatile profit margins, and decreasing equity.

**Investment Considerations:**

*   **Risk:** ALB appears to be a high-risk investment due to its volatility and underperformance relative to the market.
*   **Recent Uptrend:** The recent price increase and positive momentum indicators (RSI, PPO) suggest a potential short-term buying opportunity, but caution is advised.
*   **Long-Term Outlook:** Declining revenue, fluctuating profitability, and decreasing equity raise concerns about the company's long-term financial health.
*   **External Factors:** Investors should closely monitor news and analyst reports regarding industry trends, regulatory changes, and market events affecting Albemarle Corp, especially concerning Lithium markets.

**Recommendation:**

Given the conflicting signals (recent price uptrend vs. long-term financial concerns), a **neutral** stance is recommended. Potential investors should conduct further due diligence and closely monitor the company's financial performance, industry trends, and market conditions before making any investment decisions. The extremely high "expected return" should be heavily discounted.
